RWJ-333369

DRUG6 trials

Sponsors

SK Life Science, Inc.

Conditions

Complex Partial SeizuresEpilepsyEpilepsy, Complex PartialEpilepsy, FocalMigraine HeadachesRefractory EpilepsySeizure DisorderSeizures

Phase 2

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

CompletedNCT00109083

SK Life Science, Inc.Migraine Headaches

Start: 2002-03-31End: 2006-02-28Target: 300Updated: 2012-08-02

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

CompletedNCT00228969

SK Life Science, Inc.Refractory Epilepsy

Start: 2005-02-28End: 2006-05-31Updated: 2012-08-02

Phase 3

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

CompletedNCT00425282

SK Life Science, Inc.Complex Partial Seizures, Epilepsy, Epilepsy, Complex Partial +2

Start: 2006-11-30End: 2007-10-31Updated: 2012-06-20

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

CompletedNCT00433667

SK Life Science, Inc.Complex Partial Seizures, Epilepsy, Epilepsy, Complex Partial +2

Start: 2006-11-30End: 2007-10-31Updated: 2012-06-18

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

TerminatedNCT00697762

SK Life Science, Inc.Seizures

Start: 2007-10-31End: 2008-05-31Updated: 2013-01-23

Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

CompletedNCT00697918

SK Life Science, Inc.Seizures

Start: 2008-03-31End: 2009-04-30Updated: 2013-01-16